Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real World Experience with Biosimilar Medicines in Oncology
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    COVID-19 Patient Awareness (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Improving Cytogenetic Testing & Treatment Guidance in Adult AML
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Canada
    Acromegaly Research- United States
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Canada
    Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic Melanoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMA
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Italy
    ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy Challenge
    Release Date:
    Partner: ASTRO and Myovant Sciences
    Review Process: Expert Review Panel
    Research Oncology USA
    Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All